Supreme Court Rejects McKesson Whistleblower Kickback Claim

The US Supreme Court declined to consider reviving a federal whistleblower’s claim that McKesson Corp. unlawfully gave physicians free access to drug pricing software in exchange for commitments to buy its cancer drugs.

In an order Monday, the justices rejected Adam Hart’s appeal of a lower court’s decision to dismiss his claims that McKesson engaged in an illegal kickback scheme to encourage physicians to prescribe drugs that are paid for with federal and state funds.

The Anti-Kickback Statute prohibits health-care providers and suppliers from “knowingly and willfully” giving or receiving kickbacks to encourage purchases that are paid for by Medicare ...